| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC | Director | Common Stock | 10.9K | $2.21M | $201.47 | May 6, 2025 | Direct |
| Merus N.V. | Director | Share Option (right to buy) | 13.2K | $120K | $13.52 | May 22, 2025 | Direct |
| Replimune Group, Inc. | Director | Stock Option (right to buy) | 32K | Apr 1, 2025 | Direct | ||
| Trillium Therapeutics Inc. | Director | Stock Option (Right to Buy) | 0 | Nov 17, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MRUS | Merus N.V. | May 22, 2025 | 1 | $0 | 4 | May 27, 2025 | Director |
| WST | WEST PHARMACEUTICAL SERVICES INC | May 6, 2025 | 1 | $0 | 4 | May 8, 2025 | Director |
| REPL | Replimune Group, Inc. | Apr 1, 2025 | 1 | $0 | 4 | Apr 3, 2025 | Director |
| MRUS | Merus N.V. | May 7, 2024 | 1 | $0 | 4 | May 9, 2024 | Director |
| WST | WEST PHARMACEUTICAL SERVICES INC | Apr 23, 2024 | 1 | $0 | 4 | Apr 25, 2024 | Director |
| REPL | Replimune Group, Inc. | Apr 1, 2024 | 1 | $0 | 4 | Apr 3, 2024 | Director |
| MRUS | Merus N.V. | Jun 8, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director |
| WST | WEST PHARMACEUTICAL SERVICES INC | Apr 25, 2023 | 1 | $0 | 4 | Apr 27, 2023 | Director |
| REPL | Replimune Group, Inc. | Apr 1, 2023 | 1 | $0 | 4 | Apr 4, 2023 | Director |
| MRUS | Merus N.V. | May 31, 2022 | 1 | $0 | 4 | Jun 2, 2022 | Director |
| WST | WEST PHARMACEUTICAL SERVICES INC | May 24, 2022 | 1 | $0 | 4 | May 26, 2022 | Director |
| REPL | Replimune Group, Inc. | Apr 1, 2022 | 1 | $0 | 4 | Apr 5, 2022 | Director |
| TRIL | Trillium Therapeutics Inc. | Nov 17, 2021 | 1 | $0 | 4 | Nov 19, 2021 | Director |
| MRUS | Merus N.V. | May 28, 2021 | 1 | $0 | 4 | Jun 2, 2021 | Director |